Ruili Yin
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
-
- Air Quality and Health Impacts 2
-
- Lipid metabolism and disorders 4
- Cardiovascular Function and Risk Factors 2
- Cardiac Fibrosis and Remodeling 2
-
- Adipose Tissue and Metabolism 4
-
- Liver Disease Diagnosis and Treatment 3
-
- Chronic Kidney Disease and Diabetes 2
- Co-authors
- Longyan YangDong ZhaoYongsong XuYuanyuan ZhangXiuying ZhangKun LiYan WangLijie Zhang
- Journals
- Diabetes (1 paper)Scientific Reports (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaSaudi Arabia
In The Last Decade
Ruili Yin
20 papers receiving 323 citations
Peers
Comparison fields: 5 of 77
- Endocrinology, Diabetes and Metabolism 89
- Cancer Research 43
- Clinical Biochemistry 19
- Health, Toxicology and Mutagenesis 33
- Cardiology and Cardiovascular Medicine 50
Countries citing papers authored by Ruili Yin
This map shows the geographic impact of Ruili Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruili Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruili Yin more than expected).
Fields of papers citing papers by Ruili Yin
This network shows the impact of papers produced by Ruili Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruili Yin. The network helps show where Ruili Yin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruili Yin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 33 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 23 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 35 | |
| 13 | 2021 | 34 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 9 | |
| 16 | 2019 | 21 | |
| 17 | 2018 | 10 | |
| 18 | 2018 | 4 | |
| 19 | 2016 | 26 | |
| 20 | 2015 | 13 |
About Ruili Yin
Ruili Yin is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Clinical Biochemistry, having authored 22 papers that have together received 324 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (4 papers), Lipid metabolism and disorders (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Air Quality and Health Impacts (2 papers), Cardiovascular Function and Risk Factors (2 papers), Chronic Kidney Disease and Diabetes (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (89 citations), Cancer Research (43 citations) and Clinical Biochemistry (19 citations). Ruili Yin has collaborated with scholars based in China and Saudi Arabia. Frequent co-authors include Longyan Yang, Dong Zhao, Dong Zhao, Yongsong Xu, Yuanyuan Zhang, Xiuying Zhang, Kun Li, Yan Wang, Lijie Zhang and Shuxian Zhang. Their work appears in journals such as Diabetes, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.